Allergex Non Drowsy

C₂₂H₂₃ClN₂O₂382.90 g/mol

Ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 3957.

Registration

Applicants: 1
Registrations: 1

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Adcock ingram limited	Allergex non drowsy	tablets	360286	Not determined	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Allergex non drowsy tablets EACH TABLET CONTAINS LORATADINE 10,0 mg	Tablets	36028636/5.7.1/0286	Registered	Not determined	PI PIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

S1: Loratadine
Consolidated Schedules 06 July 2026, line 805

2 of 2 approved products with this ingredient carry S2 on their leaflet.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading Wikipedia summary

SAHPRA documents

Professional information (PI)For healthcare professionalsAllergex non drowsy tablets, Adcock ingram limited. SAHPRA's document for ALLERGEX® NON DROWSY Patient information leaflet (PIL)For patients and carersAllergex non drowsy tablets, Adcock ingram limited. SAHPRA's document for ALLERGEX® NON DROWSY

These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles